NASDAQ: ELOX
Eloxx Pharmaceuticals Inc Stock Ownership - Who owns Eloxx Pharmaceuticals?

Insider buying vs selling

Have Eloxx Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Sumit AggarwalPresident and CEO2026-02-28260,946$0.15
$39.14kBuy

1 of 1

ELOX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ELOX insiders and whales buy or sell their stock.

ELOX Shareholders

What type of owners hold Eloxx Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Paul Edward Klaver2,309.96%27,439,581$332.29MInsider
Christopher Forbes1,073.95%12,757,318$154.49MInsider
Ran Nussbaum412.52%4,900,249$59.34MInsider
Tomer Kariv412.52%4,900,249$59.34MInsider
Pontifax Management III GP 2011 Ltd412.52%4,900,249$59.34MInsider
Rajesh B. Parekh406.36%4,827,129$58.46MInsider
Gilad Shabtai282.16%3,351,770$40.59MInsider
Martijn Kleijwegt248.65%2,953,673$35.77MInsider
Harlan Waksal236.20%2,805,750$33.98MInsider
Vaughn Smider178.30%2,117,940$25.65MInsider

1 of 3

ELOX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ELOX0.00%100.00%Net Buying
CYCN3.74%73.81%
KTTA38.36%38.98%Net BuyingNet Buying
RKTO4.11%42.24%Net Selling
QNRX1.69%6.75%Net Buying

Eloxx Pharmaceuticals Stock Ownership FAQ

Who owns Eloxx Pharmaceuticals?

Eloxx Pharmaceuticals (NASDAQ: ELOX) is owned by 0.00% institutional shareholders, 6,896.79% Eloxx Pharmaceuticals insiders, and 0.00% retail investors. Paul Edward Klaver is the largest individual Eloxx Pharmaceuticals shareholder, owning 27.44M shares representing 2,309.96% of the company. Paul Edward Klaver's Eloxx Pharmaceuticals shares are currently valued at $351.50M.

If you're new to stock investing, here's how to buy Eloxx Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.